➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Medtronic
AstraZeneca
McKinsey
Colorcon

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Esreboxetine


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Esreboxetine?

Esreboxetine is an investigational drug.

There have been 4 clinical trials for Esreboxetine. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2009.

The most common disease conditions in clinical trials are Fibromyalgia, Myofascial Pain Syndromes, and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for Esreboxetine
TitleSponsorPhase
Maintenance of Efficacy.PfizerPhase 3
Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of EsreboxetinePfizerPhase 1
Phase 1 Thorough QT (TQT) Study in Young Healthy VolunteersPfizerPhase 1

See all Esreboxetine clinical trials

Clinical Trial Summary for Esreboxetine

Top disease conditions for Esreboxetine
Top clinical trial sponsors for Esreboxetine

See all Esreboxetine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Harvard Business School
Johnson and Johnson
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.